MCM
ADMS

MAI Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

MAI Capital Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-667,546
Closed -$3.28M – 957
2021
Q3 		$3.28M Buy
667,546
+123,730
+23% +$601K 0.06% 174
2021
Q2 		$2.87M Buy
+543,816
New +$2.81M 0.06% 192

MAI Capital Management's ADMS Position: Q4 2021 in Review

MAI Capital Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 667,546 shares — an estimated $3.28M sold.

MAI Capital Management first reported a position in ADMS in Q2 2021 and held it in 2 quarters. The position peaked at $3.28M in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

  • MAI Capital Management reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • MAI Capital Management sold 667,546 Adamas Pharmaceuticals shares in Q4 2021, an estimated $3.28M.
  • MAI Capital Management first reported a position in Adamas Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • MAI Capital Management's Adamas Pharmaceuticals position peaked at $3.28M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on MAI Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.